EVE-112 Vaginal Ring

Product Overview

Alternative Name: Etonogestrel (ENG) + ethinylestradiol (EE) vaginal ring; EVE112

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Vaginal Ring

Duration Type: Short-acting

Description: A vaginal ring expected to be a bioequivalent to NuvaRing. The new vaginal delivery system has not been disclosed and is being considered for a patent application.

Updated date: May 30, 2018

Vertical Tabs


Project Phase: Late Development

Project Stage: Phase II

Status Details:
  • Phase-II clinical trials are taking place in Germany and pre-clinical trials are underway in USA.

Download Product Report